CTNM
#3127
Contineum Therapeutics, Inc. - Common stock
16.2 4 USD
-0.05%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.75%
Variación mensual
+6.70%
Variación en los últimos 6 meses
+7.27%
Cambio anual
+6.35%
Cierres anteriores
17.0 5
Open
16.2 4
Mínimo
16.2 4
Máximo
16.2 4
Volumen
76
Financials
- Market Capitalization 375.13 M
- Employee 51
- Founded 2009
- CEO N/A
- Website www.contineum-tx.com
- Headquarter Delaware, United States
- FIGI BBG01M27SVP6
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3103 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.33 USD | -1.99% | -5.19% | +4.96% | +53.22% | 388.24 M USD | ||
| 3104 |  EYPT EyePoint, Inc. - Common Stock | 4.50 USD | +0.45% | -9.64% | -63.53% | -62.50% | 387.95 M USD | ||
| 3134 |  IPSC Century Therapeutics, Inc. - Common Stock | 2.05 USD | +0.99% | -3.76% | 0.00% | +318.37% | 371.20 M USD | ||
| 3178 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.32 USD | -1.45% | -4.66% | +9.73% | -40.80% | 350.91 M USD |